
Marwan Fakih/X
Apr 14, 2025, 17:39
Marwan Fakih: Meaningful clinical benefits for KRAS G12C MCRC
Marwan Fakih, Associate Director for Clinical Sciences at City of Hope, shared a post on X about a paper he co-authored with colleagues published in the Journal of Clinical Oncology:
“Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator’s Choice in Chemorefractory KRAS G12C Colorectal Cancer | Journal of Clinical Oncology.
Meaningful clinical benefits for KRAS G12C MCRC!”
Authors: Filippo Pietrantonio, Lisa Salvatore, Taito Esaki, Dominik Paul Modest, David Paez Lopez-Bravo, Emily Chan, Joseph Chao, Qui Tran, Chiara Cremolini, Marwan Fakih et al.
More posts featuring Marwan Fakih.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 15, 2025, 12:02
Apr 15, 2025, 11:54
Apr 15, 2025, 11:52
Apr 15, 2025, 11:46
Apr 15, 2025, 11:30
Apr 15, 2025, 11:00
Apr 15, 2025, 10:23